{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:02:28Z","timestamp":1790539348996,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.cll.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:45:16Z","timestamp":1593711916000},"page":"357-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic Testing for Patients with Spinal Muscular Atrophy"],"prefix":"10.1016","volume":"40","author":[{"given":"John F.","family":"Brandsema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna N.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Matesanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cll.2020.05.005_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of\u00a0>72 400 specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.cll.2020.05.005_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cll.2020.05.005_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function","author":"Swoboda","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cll.2020.05.005_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.cll.2020.05.005_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"Finkel","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.cll.2020.05.005_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ana.25101","article-title":"Natural history of infantile-onset spinal muscular atrophy","volume":"82","author":"Kolb","year":"2017","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.cll.2020.05.005_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-019-0568-z","article-title":"Current treatment options in neurology\u2014SMA therapeutics","volume":"21","author":"Waldrop","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"18","key":"10.1016\/j.cll.2020.05.005_bib9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cll.2020.05.005_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.cll.2020.05.005_bib11","doi-asserted-by":"crossref","first-page":"e2492","DOI":"10.1212\/WNL.0000000000007527","article-title":"Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1\/2 studies","volume":"92","author":"Darras","year":"2019","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.cll.2020.05.005_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2020.05.005_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pediatrneurol.2019.06.007","article-title":"From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA type 1","author":"Al-Zaidy","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"15 Supplement","key":"10.1016\/j.cll.2020.05.005_bib14","first-page":"S25","article-title":"Nusinersen in infants who initiate treatment in a presymptomatic stage of spinal muscular atrophy (SMA): interim efficacy and safety results from the phase 2 NURTURE study (S25.001)","volume":"92","author":"De Vivo","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.cll.2020.05.005_bib15","series-title":"Neuromuscular disorders of infancy, childhood, and adolescence","first-page":"117","article-title":"Spinal muscular atrophies","author":"Darras","year":"2015"},{"key":"10.1016\/j.cll.2020.05.005_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cll.2020.05.005_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/geno.1996.0147","article-title":"Structure and organization of the human survival motor neurone (SMN) gene","volume":"32","author":"B\u00fcrglen","year":"1996","journal-title":"Genomics"},{"issue":"9","key":"10.1016\/j.cll.2020.05.005_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/gt.2017.52","article-title":"The clinical landscape for SMA in a new therapeutic era","volume":"24","author":"Talbot","year":"2017","journal-title":"Gene Ther"},{"key":"10.1016\/j.cll.2020.05.005_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/GIM.0b013e318220d523","article-title":"Technical standards and guidelines for spinal muscular atrophy testing","author":"Prior","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.cll.2020.05.005_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.cll.2020.05.005_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/14737159.4.1.15","article-title":"Spinal muscular atrophy: molecular genetics and diagnostics","volume":"4","author":"Ogino","year":"2004","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cll.2020.05.005_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-60761-947-5_8","article-title":"Multiplex ligation-dependent probe amplification (MLPA \u00ae) for the detection of copy number variation in genomic sequences","volume":"688","author":"Eijk-Van Os","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.cll.2020.05.005_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ejhg.2012.62","article-title":"Clinical utility gene card for: proximal spinal muscular atrophy","volume":"20","author":"Rudnik-Sch\u00f6neborn","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.cll.2020.05.005_bib24","first-page":"188","article-title":"Gene dosage analysis of proximal spinal muscular atrophy carriers using real-time PCR","volume":"14","author":"Abbaszadegan","year":"2011","journal-title":"Arch Iran Med"},{"issue":"4 SUPPL","key":"10.1016\/j.cll.2020.05.005_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1590\/S1415-47572012000600010","article-title":"Molecular analysis of spinal muscular atrophy: a genotyping protocol based on TaqMan\u00ae real-time PCR","volume":"35","author":"Godinho FM de","year":"2012","journal-title":"Genet Mol Biol"},{"issue":"8955","key":"10.1016\/j.cll.2020.05.005_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(95)90732-7","article-title":"PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy","volume":"345","author":"van der Steege","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2020.05.005_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2016.215","article-title":"The next generation of population-based spinal muscular atrophy carrier screening: comprehensive pan-ethnic SMN1 copy-number and sequence variant analysis by massively parallel sequencing","author":"Feng","year":"2017","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.cll.2020.05.005_bib28","first-page":"418","article-title":"[Sanger sequencing for the diagnosis of spinal muscular atrophy patients with survival motor neuron gene 1 compound heterozygous mutation]","volume":"97","author":"Yang","year":"2017","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.cll.2020.05.005_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the Association for Molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.cll.2020.05.005_bib30","unstructured":"Health Bureau of the Health C. Newborn Screening for Spinal Muscular Atrophy A Summary of the Evidence and Advisory Committee Decision.; 2018. Available at: https:\/\/www.hrsa.gov\/sites\/default\/files\/hrsa\/advisory-committees\/heritable-disorders\/rusp\/previous-nominations\/sma-consumer-summary.pdf"},{"key":"10.1016\/j.cll.2020.05.005_bib32","author":"Matern"},{"key":"10.1016\/j.cll.2020.05.005_bib33","article-title":"Pilot study of population-based newborn screening for spinal muscular atrophy in New York state","volume":"20","author":"Kraszewski","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.cll.2020.05.005_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2017.06.042","article-title":"Presymptomatic diagnosis of spinal muscular atrophy through newborn screening","volume":"190","author":"Chien","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.cll.2020.05.005_bib35","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1373\/clinchem.2018.293712","article-title":"Multiplex droplet digital PCR method applicable to newborn screening, carrier status, and assessment of spinal muscular atrophy","volume":"64","author":"Vidal-Folch","year":"2018","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.cll.2020.05.005_bib36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1373\/clinchem.2014.231019","article-title":"Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency","volume":"61","author":"Taylor","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2020.05.005_bib37","author":"Romero"},{"issue":"9","key":"10.1016\/j.cll.2020.05.005_bib38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jmg.2009.066969","article-title":"Differences in SMN1 allele frequencies among ethnic groups within North America","volume":"46","author":"Hendrickson","year":"2009","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.cll.2020.05.005_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/GIM.0b013e318188d069","article-title":"Carrier screening for spinal muscular atrophy","volume":"10","author":"Prior","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.cll.2020.05.005_bib40","series-title":"Embryology - theory and practice","article-title":"Introductory chapter: new theory and technology in early clinical embryogenesis","author":"Wu","year":"2019"},{"issue":"10","key":"10.1016\/j.cll.2020.05.005_bib41","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41431-018-0193-4","article-title":"Utility of two SMN1 variants to improve spinal muscular atrophy carrier diagnosis and genetic counselling","volume":"26","author":"Al\u00edas","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"10.1016\/j.cll.2020.05.005_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/gim.2013.84","article-title":"An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy","volume":"16","author":"Luo","year":"2014","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.cll.2020.05.005_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/uog.15945","article-title":"ISUOG practice guidelines: invasive procedures for prenatal diagnosis","volume":"48","author":"Ghi","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.cll.2020.05.005_bib44","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/dex265","article-title":"ESHRE PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013","volume":"32","author":"De Rycke","year":"2017","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.cll.2020.05.005_bib45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4103\/jhrs.JHRS_132_18","article-title":"Preimplantation genetic testing: its evolution, where are we today?","volume":"11","author":"Parikh","year":"2018","journal-title":"J\u00a0Hum Reprod Sci"},{"issue":"1","key":"10.1016\/j.cll.2020.05.005_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ogc.2017.10.009","article-title":"Preimplantation genetic screening and preimplantation genetic diagnosis","volume":"45","author":"Sullivan-Pyke","year":"2018","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.cll.2020.05.005_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bpobgyn.2017.04.001","article-title":"Preimplantation genetic diagnosis for monogenic diseases","volume":"44","author":"Lee","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.cll.2020.05.005_bib48","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10897-016-9975-4","article-title":"Preimplantation genetic diagnosis (PGD) for monogenic disorders: the value of concurrent aneuploidy screening","volume":"25","author":"Goldman","year":"2016","journal-title":"J\u00a0Genet Couns"},{"issue":"2","key":"10.1016\/j.cll.2020.05.005_bib49","first-page":"145","article-title":"Treatment algorithm for infants diagnosed with spinal muscular atrophy through newborn screening","volume":"5","author":"Glascock","year":"2018","journal-title":"J\u00a0Neuromuscul Dis"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271220300378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271220300378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:56:22Z","timestamp":1759449382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271220300378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0272271220300378"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2020.05.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Testing for Patients with Spinal Muscular Atrophy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}